In the fight against COVID-19, ImmunoScape is joining forces with Dr. Patrick Reeves, Team Leader at the Massachusetts General Hospital Vaccine & Immunotherapy Center, using its signature assay, TargetScape, to perform high-dimensional immune profiling of COVID-19...
October 21-25, 2020 Please join our oral presentation on, “Broad and Prevalent SARS-CoV-2 CD8+ T Cell Response in Recovered COVID-19 Individuals Demonstrates Kinetics of Early Differentiation” and meet our team! Session Date: Saturday October 24,...
August 27-29, 2020 Virtual event ImmunoScape and Gilead Sciences recently presented findings at the Digital International Liver Congress 2020 that demonstrated the feasibility of simultaneously identifying and deeply characterizing rare HBV-specific T cells in...
As part of a collective effort in fighting COVID-19, ImmunoScape is collaborating with Arcturus Therapeutics, a developer of RNA therapeutics for treatment and prevention of diseases with high unmet medical needs, and Duke-NUS, who will be running the clinical trial...
The funds enable ImmunoScape to bring its unique immune-profiling capability to major biopharma companies globally, accelerating development of vital immunotherapies and other medicines PDF Version SINGAPORE and SAN DIEGO, August 12, 2020, /PRNewswire/ —...
